2-Heterocyclylmercaptoalkyl
penems were synthesized and their in vitro potency was established.
The compounds exhibit moderate to strong antibacterial activity against various
Gram-positive and Gram-negative bacteria. Their antimicrobial activity is related to the nature of the heterocycle, the length of the hydrocarbon spacer between the 2-position of the penem nucleus and the mercapto group, and the substitution pattern of the C-6 position of the penem skeleton.
In recent years, we have been engaged1,3) in extensive studies of the influence of the C-2 substituent of the penem nucleus on the antimicrobial activity of the substances. Although a few 2-heterocyclylmercaptomethyl derivatives were described in the 6-(1-R-hydroxyethyl) series4,5) we decided to examine penem derivatives 1 (Table 1) with the more easily accessible 6-hydroxymethyl group, or with an extended C-2 hydrocarbon side-chain, or both.
Chemistry
According to WOODWARD'S strategy6), the penem nucleus was obtained by an intramolecular
Wittig cyclization of the appropriate phosphoranes 6 and 7.
The (5R,6S)-6-hydroxymethyl-2-methyl derivatives 8a'h were synthesized (Scheme 1) by two different methods; substitution of the methylsulfonyl leaving group in the azetidinone 2 with tritylmercaptan, formation of the phosphorane by the widely used and classical three-step procedure 7-9) (i.e. condensation of the glyoxylate at the NH group of the azetidinone, conversion to the chloride with SOCI2 and subsequent reaction with PhP to the phosphorane), conversion to the silver thiolate 5 with silver nitrate in methanol by analogy with known procedures10,11) and acylation with chloroacetylchloride provided the key compound 6. A nucleophilic displacement of the chlorine by thiolates afforded the phosphoranes 7a, d " h, and subsequent thermolysis the corresponding penems 8a, d -h.
The alternative method is based on the prior cyclization of the key phosphorane 6 to the penem 9, followed by the substitution of the chlorine to afford compounds 8b, c.
The (5R,6S)-6-(I'R-hydroxyethyl)penem 8i was obtained (Scheme 2) in seven steps from the 3-tert-butyldimethylsilyloxyethyl-4-tent-butylsulfonylazetidinone 10. The replacement of the tert-butylsulfonyl moiety by a tritylthio group (10->11), construction of the phosphorane 12 by the three-step procedure, and subsequent cleavage of the S-trityl bond with silver nitrate in methanol afforded the silver thiolate 13, acylation of which with 1-methyltetrazol-5-ylacetyl chloride gave the phosphorane 7i.
The Wittig cyclization readily yielded the corresponding penern 8i. afforded small amounts of a by-product identified as the isomeric 2-exomethylidene pertains5). This problem was solved by inverting the reaction sequence, i.e. by deblocking first the hydroxyl-function in the phosphoranes 7 and then cyclizing the latter to the 6-hydroxymethyl (or 6-hydroxyethyl) penems.
Finally an either by Pd catalyzed deprotection of the allyl ester with tributyltinhydride (8a-j, o)
or splitting of the trimethylsilylethyl ester with fluoride anions14) (8n).
This last procedure was also used for the deprotection of the C-6 unsubstituted penems 8k, 1, m. Antimicrobial Activity
The minimum inhibitory concentration (MIC) values of the 2-heterocyclylthioalkylpenems 1 for selected strains of Gram-positive and Gram-negative bacteria were determined by the agar dilution technique15). Table 1 lists the activities of a series of penem compounds with different C-6 substituents and various lengths of the C-2 carbon side-chain terminally substituted by the heterocyclic mercaptans commonly used in the cephalosporin series.
With the exception of the sodium salt of (4-mercaptotetrazol-l-yl)acetic acid (cf. 1b), which possessed only moderate Gram-positive activities, all the heterocyclic substituents examined proved to be equally good. Penem compounds featuring no substituent at the C-6 position, although stable against /3-lactamases of the Gram-positive strains, were unstable against the r3-lactamases produced by Gramnegative bacteria and, in contrast to C-6 substituted penems, only moderately active against anaerobes.
Despite a slight gain on the Gram-positive side of the spectrum an increase in the length of the C-2 carbon side-chain induces a perceptible loss of activity on the Gram-negative side.
As observed earlier with other compounds in the penem series, and in striking contrast to thienamycin derivatives16), none of the tested substances showed any significant activity against Pseudomonas. VOL. XXXIX NO. 4 THE JOURNAL OF ANTIBIOTICS
Conclusions
Penem compounds bearing a 2-hcterocyclylthioalkyl side-chain displayed a high degree of antibacterial activity, except against Pseudomonas. The 6-(1'R-hydroxyethyl) and the more easily accessible 6-hydroxymethyl derivatives proved to be about equally active, and in contrast to the 6-unsubstituted penems, stable against 13-lactamase-producing strains (Table 1) . With increasing length of the C-2 carbon side-chain, Gram-negative activity diminishes.
Experimental IR spectra were obtained using a Perkin-Elmer apparatus Model 983G (main absorptions given in cm-1). The UV spectra were recorded on a Cary 118 instrument. The 60 MHz 'H NMR spectra were recorded on a Varian EM 360 A and the 360 MHz spectra on a Brucker HX 360 apparatus. The signals are listed in o values (TMS 0.0). Melting points are uncorrected.
Antibiotic Susceptibility All in vitro antibacterial activities are given as MIC in tug/ml. MICs were determined by the conventional agar dilution technique15) using Diagnostic Sensitivity Test agar (Oxoid) enriched with 1 % supplement C (Difco) after overnight incubation at 37°C and an inoculum of about 103 cfu/ml. Phosphoranes General Preparation of Phosphoranes 7a, d-h, k-m, o; Phosphorane 7a: Pyridine (1.32 ml), 4-dimethylaminopyridine (60 mg) and chloroacetyl chloride (0.6 ml) were added successively to an icecooled, stirred solution of the silver thiolate 5, (3.56 g), prepared in four steps by analogy with known procedures10,11) in abs CH2C12 (100 ml). After 30 minutes at 0°C the reaction mixture was filtered and after dilution with CH2C12, washed with aq NaHCO3and brine, then dried (Na2SO4) and evaporated in vacuo to give, after column chromatography (toluene -EtOAc, 95: 5), the intermediate phosphorane 6 (2.15 g): IR (CH2C12) cm-' 1750, 1680, 1615.
The phosphorane 6 (1.6 g) was dissolved in abs DMF (5 ml) and treated dropwise with a solution of sodium (1-mehyltetrazol-5-yl)thiolate (0.325 g) in abs DMF (5 ml). After 0.75 hour the reaction mixture was poured on ice water, and the insoluble title phosphorane 7a (1.7 g) was obtained after filtration and drying in vacuo: IR (CH2Cl2) cm-1 1750, 1670, 1615.
General Preparation of Phosphoranes 7i, j; Phosphorane 7j: To a solution of the silver thiolate 5 (4.5 g) in abs CH2Cl2 (100 ml) at 0°C were added pyridine (1.26 ml), 4 dimethylaminopyridine (20 mg) and, dropwise, a solution of 4-(1-methyltetrazolyl)mercaptopropionyl chloride (1.6 g). After 30 minutes the silver chloride was filtered off and, after dilution with CHZC12i the solution washed with aq NaHCO3 and brine and finally dried (Na2SO4). Evaporation in vacuo of the solvent and purification by chromatography (toluene -EtOAc, 4: 1) gave the title compound 7j (I g) : IR (CH2Cl2) cm-1 1750, 1685, 1620. Phosphorane 7n; Ethyl-4-(I-methyltetrazolyhnercapto)butyrate: To a stirred solution of ethyl-4-bromobutyrate (6.44 g) in abs EtOH (60 ml) were added sodium (1-methyltetrazolyl)thiolate (5.34 g). After 30 minutes at 90°C the solvent was evaporated in vacuo. The residue was partitioned between H2O and EtOAc and the separated organic layer was dried over Na2SO4. After evaporation of the solvent in vacuo, the crude material was purified by column chromatography (SiO2; eluant: tolueneEtOAc, 1: 1) to afford 7.07 g of the title compound. IR (CH2C12) cm-1 1730, 1370, 1160, 'H NMR (60 MHz, CDC13) 1.27 (3H, t, CH3), 1.9-2.65 (4H, 2m, 2CH,), 3.43 (2H, t, CH2), 4.0 (3H, s, CH3), 4.17 (2H, q, CH,).
4-(1-Met hyltetrazolylmercapto)butyric Acid: To a stirred solution of ethyl-4-(l-methyltetrazolylmercapto)butyrate (21.8 g) in THE (478 ml) was added a solution of 1 N NaOH (143 nil). After stirring for 3 hours at room temp, the solution was concentrated in vacuo and washed with EtOAc. The aq phase was transferred to an ice-bath, acidified to pH 3 by addition of 4 N HCl (30 ml) and extracted with EtOAc (3 x 80 ml). The extracts were dried (Na2SO4) and evaporated in vacuo to leave the pure title compound (17.79 g): IR (CH,CI), cm-' 3500, 2500, 1700; 'H NMR (60 MHz, CDC13) 2.17 (2H, m, CH,), 2.5 (2H, m, CH2), 3.47 (2H, t, CH2), 4.0 (3H, s, CH,), 8.8 (1 H, br s, COOH). 3 (2H, m, CH2), 3.17 (2H, t, CH2), 3.43 (2H, t, CH2), 3.98 (3H, s, CH3 ).
4-(1-Methyltetrazolymmercapto)thiobutyric Acid: A solution of 4-(1-methyltetrazolylmercapto)-butyroyl chloride (0.92 g) in dry CH.,Cl2 (1.4 ml) was added dropvise to an ice-cooled solution (5.54 ml) of pyridine and H.S in CH2Cl2. (The stock solution is prepared by dissolution of H_S (6 g) in a pyridine (30 ml) and CHCI, (100 ml) solution). After stirring for 1 hour at 0°C under a nitrogen atmosphere, the reaction mixture was diluted with CH2Cl2 and acidified with 2 N H,SO,. After separation of the organic phase and two further extractions with CH2CI2 the combined organic layers were extracted twice with 10% NaHCO3 (5 ml). The extracts were reacidified with 2 N H2SO4 (pH 3) and washed twice with CH2Cl2; the combined organic layers were dried and evaporated to give the title compound (0.75 g): IR (CH2Cl2) cm-' 2575, 1695; 'H NMR (60 MHz, CDCl3) 2.2 (2H, m, CH2), 2.9 (2H, t, CH2), 3.43 (2H, t, CH2), 3.97 (3H, s, CH3), 4.35 (1H, br s, COSH).
To a stirred solution of 212) (0.88 g) in dry THE (6 ml) was added dropwise, at room temp, 4-(l-methyltetrazol-5-ylmercapto)thiobutyric acid (0.72 g) dissolved in 0.33 N NaOH (10 ml). The pH was kept between 9 and 10 by addition of 0.33 N NaOH, and after 3.5 hours the reaction mixture was extracted with CH2CI2. The combined organic extracts were washed with brine, dried (Na2SO4) and evaporated in vacuo. The title compound (0. After stirring at 100°C for 8 hours, the mixture was filtered, the solvents evaporated under vacuum and the crude hydroxyl derivative dissolved in THE (35 ml) and subsequently reacted at -15°C over 10 minutes with thionyl chloride (1.04 ml) and N(Et)3 (2.08 ml). After l hour at 0°C, the reaction mixture was filtered and evaporated ill vacuo to leave the corresponding chloride. The latter was dissolved without further purification in dioxane (20 ml) treated with Ph,P (2.25 g) and 2,6-lutidine (1 ml) and stirred for 18 hours at 50°C. The reaction mixture was finally filtered and the pure title compound 7n (2. General Preparation of the Penems 8b, c; Penem 8c: A stirred solution of phosphorane 6 (0.341 g) in abs toluene (15 ml) was heated at 90°C for 45 minutes. After evaporation of the solvent in vacuo, the crude 9 (IR (CH2CI2) cm-' 1785, 1705, 1580) was dissolved in DMF (1 ml) and treated dropwise with a solution of (1-carbamoy]methyltetrazol-5-yl)thiol (0.087 g) and N,N-diisopropylethylamine (0.094 ml) in DMF (0.5 ml). The reaction mixture was partitioned between H2O and EtOAc, and the organic phase separated, washed with H2O and brine, dried (Na2SO,) and evaporated to dryness. Chromatographic purification (EtOAc) yielded the title compound 8c (0. To a stirred solution of this penem (0.265g) in abs THE (10 ml) were added at -10°C tetrakis(triphenylphosphine)palladium (15 mg) and tributyltin hydride (0.22 ml). After 20 minutes at the same temp AcOH (0.047 ml) was added and the reaction mixture was concentrated in 
